ORASURE TECHNOLOGIES INC (OSUR) 8-K Current Report: February 25, 2026
Filed: February 25, 2026
Health Care
Surgical & Medical Instruments & ApparatusORASURE TECHNOLOGIES INC (OSUR) 8-K current report filed with SEC EDGAR on February 25, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items2 items
- Item 2.02: Results of Operations and Financial Condition
- Item 7.01: Regulation FD Disclosure
ORASURE TECHNOLOGIES INC 8-K Feb 25, 2026 Event Analysis
Item 2.02 · Results of Operations and Financial Condition
- • Q4 and full-year 2025 earnings released Feb 25, 2026 — full results in Exhibit 99.1
- • Period covered: fiscal year and quarter ended December 31, 2025
- • No financial figures disclosed in 8-K body — all key metrics (revenue, EPS, margins) in press release exhibit
Item 7.01 · Regulation FD Disclosure
- • OSUR management hosted analyst/investor webcast Feb 25, 2026 covering full-year and Q4 2025 financial results
- • CEO Carrie Eglinton Manner and CFO Kenneth McGrath led call — key executives to monitor for forward guidance signals
- • Investor presentation (Exhibit 99.2) available on orasure.com — primary source for business development updates and financial detail
Other ORASURE TECHNOLOGIES INC 8-K Filings
Get deeper insights on ORASURE TECHNOLOGIES INC
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.